Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Xencor Inc (XNCR)  
$22.42 0.89 (4.13%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 66,383,000
Market Cap: 1.49(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $16.53 - $29.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 2
Insider 6 Months    : 2
Insider 3/6 Months : 4.3
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. Co. is developing a portfolio of clinical-stage XmAb® drug candidates from its protein engineering technology platforms. Co.'s XmAb bispecific Fc drug candidates include: Vudalimab (XmAb717), which is a bispecific antibody that targets PD-1 and CTLA-4 and for patients with metastatic castration-resistant prostate cancer and other solid tumor types; and Plamotamab, which is a bispecific antibody that targets CD20, an antigen on B-cell tumors, and CD3, an activating receptor on T cells.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 53 53 53 53
Total Buy Value $1,013 $1,013 $1,013 $1,013
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 146,351 146,351 179,848 214,693
Total Sell Value $3,094,133 $3,094,133 $3,971,419 $5,040,525
Total People Sold 5 5 5 6
Total Sell Transactions 11 11 12 27
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 312
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-03-11 4 S $23.50 $30,082 D/D (1,280) 186,433 7%     
   Kuch John J SR. VICE PRESIDENT & CFO   •       •      –    2024-03-11 4 S $23.50 $19,953 D/D (849) 121,070 7%     
   Eckert Celia SVP, GENERAL COUNSEL   •       •      –    2024-03-11 4 S $23.50 $19,977 D/D (850) 45,465 7%     
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2024-03-11 4 S $23.50 $64,418 D/D (2,741) 351,894 7%     
   Gustafson Kurt A Director   •       •      –    2024-03-06 4 S $23.18 $324,453 D/D (14,000) 6,007 10%     
   Gustafson Kurt A Director   •       •      –    2024-03-06 4 OE $10.73 $160,950 D/D 15,000 20,007     -
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2024-03-05 4 A $0.00 $0 D/D 54,538 354,635     -
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2024-03-05 4 S $23.43 $293,519 D/D (12,528) 300,097 6%     
   Kuch John J SR. VICE PRESIDENT & CFO   •       •      –    2024-03-05 4 S $23.43 $104,821 D/D (4,474) 121,919 6%     
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-03-05 4 A $0.00 $0 D/D 20,724 187,713     -
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-03-05 4 S $23.43 $155,311 D/D (6,629) 166,989 6%     
   Eckert Celia SVP, GENERAL COUNSEL   •       •      –    2024-03-05 4 A $0.00 $0 D/D 13,089 46,315     -
   Eckert Celia SVP, GENERAL COUNSEL   •       •      –    2024-03-05 4 S $23.43 $91,186 D/D (3,892) 33,226 6%     
   Valente Nancy EVP, Chief Development Officer   •       •      –    2024-03-05 4 A $0.00 $0 D/D 19,634 59,860     -
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-02-14 4 OE $11.05 $131,970 D/D 11,943 173,618     -
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-02-13 4 AS $19.38 $1,048,743 D/D (54,108) 161,675 18%     
   Desjarlais John R SR. VICE PRESIDENT & CSO   •       •      –    2024-02-13 4 OE $11.05 $752,030 D/D 68,057 215,783     -
   Gorman Kevin Charles Director   •       •      –    2024-02-13 4 B $19.12 $1,013 D/D 53 5,060 2.31 13%     
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2023-12-29 4 S $20.93 $941,670 D/D (45,000) 312,929 -1%     
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2023-12-29 4 OE $11.05 $718,261 D/D 65,001 357,929     -
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2023-06-21 4 S $26.19 $877,286 D/D (33,497) 292,216 35%     
   Dahiyat Bassil I PRESIDENT & CEO   •       •      –    2023-06-21 4 OE $4.25 $323,051 D/D 76,012 325,713     -
   Gustafson Kurt A Director   •       •      –    2023-06-20 4 A $0.00 $0 D/D 5,007 5,007     -
   Feigal Ellen Director   •       •      –    2023-06-20 4 A $0.00 $0 D/D 5,007 5,007     -
   Montgomery Alan Bruce Director   •       •      –    2023-06-20 4 A $0.00 $0 D/D 5,007 5,007     -

  312 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed